Steatotic Liver Disease: What You Need to Know, Part 2. Dual Threats—Advancing Research and Care in Steatotic Liver Disease
Nov
08
2025
Convention Center: Ballroom A, Level 3
2:00 PM - 3:30 PM
World Class Speakers
Description
Presenters in this session focus on advancing research and therapeutic strategies for steatotic liver disease (SLD), with an emphasis on MASLD and its subtypes. Discussions highlight lifestyle interventions, pharmacologic treatments, and global health perspectives. Experts address the challenges of implementing evidence-based care and explore innovations that improve outcomes for diverse patient populations.Presentations
2:00 PM - 2:15 PM
Nov
08
2025
San Diego, CA
Nutrition in Steatotic Liver Disease: What Is the Best Approach in MetALD?
Shira Zelber-Sagi, PhD, Presenter
ALD
MASLD
2:15 PM - 2:30 PM
Nov
08
2025
San Diego, CA
How Do I Prescribe Exercise in Steatotic Liver Disease?
Jonathan G Stine, MD, MSc, Presenter
ALD
MASLD
2:30 PM - 2:45 PM
Nov
08
2025
San Diego, CA
Role of Resmetirom in Steatotic Liver Disease: Beyond MASLD?
Naim Alkhouri, MD, FAASLD, Presenter
ALD
MASLD
2:45 PM - 3:00 PM
Nov
08
2025
San Diego, CA
Role of Semaglutide and Glucagon-Like Peptide-1 Receptor Agonists in Steatotic Liver Disease
Alina M. Allen, MD, Presenter
ALD
MASLD
3:00 PM - 3:15 PM
Nov
08
2025
San Diego, CA
MetALD: What Did We Learn During the Last Year?
Gene Im, MD, FAASLD, Presenter
ALD
MASLD
3:15 PM - 3:30 PM
Nov
08
2025
San Diego, CA
Q&A Session
Alina M. Allen, MD, Moderator
ALD
MASLD
Objectives
- Identify and evaluate advancements in research and care for steatotic liver disease (SLD).
- Explain the roles of nutrition, exercise, and pharmacotherapy in the comprehensive management of SLD.
- Review gaps in care delivery and strategies to mitigate global disparities in SLD outcomes.
Chair
Juan Pablo Arab, MD, FRCPC
Virginia Commonwealth University
Chair
Mazen Noureddin, MD, MHSc
Houston Methodist Hospital